Notizie/Azora Therapeutics Establishes Bd of Directors With Extensive Drug Development and Inflammatory Bowel Disease ExpertiseFlashAzora Therapeutics Establishes Bd of Directors With Extensive Drug Development and Inflammatory Bowel Disease ExpertiseAZRQuesta notizia mostra solo il titolo e non contiene altro testo.AmministrazioneAzioni USADow Jones Newswires© 2026 Dow Jones & Company, Inc. All rights reserved.Mostra di più
